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Summary 
Background: The essential physical role, visibility and social importance of the hands 
pose a major psychological burden on patients with hand eczema.  
Objectives: The aim of this study was to identify the psychological, social and clinical 
characteristics of patients with hand eczema, in particular the prevalence of depression, 
anxiety, suicidal ideation and comorbidities.  
Materials and methods: Data on patients with hand eczema were analysed from a large 
European, multicenter, study conducted on dermatology outpatients from 13 countries. 
Groups of patients and controls were compared to analyse the psychological burden of 
hand eczema. 
Results: Women patients with hand eczema had higher Hospital Anxiety and 
Depression Scale (HADS) scores for anxiety (n=86, median=7.0) than controls (n=900, 
5.0, p=0.02), and for depression (median=4.0) than controls (3.0, p<0.001). Patients 
with high suicidal ideation, low socioeconomic status and who were widowed or 
divorced were more likely to fulfil the HADS criteria for anxiety [(Odds ratio (OR)>1, 
p=0.038, p<0.001 and p<0.001 respectively]. The median DLQI score was 7.0 (n=68). 
Discussion: This study identifies a specific psychological burden experienced by hand 
eczema patients, highlighting the need for focused psychosocial interventions. In 
particular physicians should be aware of the need to identify anxiety and depression in 
women patients. 
Key words: hand eczema; anxiety; depression; stress; psychosocial burden; gender 
differences; quality of life, outpatients 
 
 
 
 
 
 
 
Introduction 
Skin conditions and skin-related diseases are amongst the most common human 
illnesses, implying both a high prevalence and a wide range of detrimental psychical 
and psychological effects. The global impact of skin conditions collectively represents 
the fourth largest cause of nonfatal disease, as measured in years lost due to disability 
(1). In the literature, the high prevalence of skin conditions is well recognised (2, 3, 4), 
as is the strong association between psychiatric disorders and skin disease (5, 6, 7, 8). 
The full extent of psychological comorbidity from skin disease across Europe was 
revealed in a large European multicentre study (9). That study included patients with 
hand eczema, giving the opportunity to specifically analyse the psychosocial burden 
caused by hand eczema. 
Hand eczema has a considerable impact in various workplace and professional settings. 
There is a significant association between having hand eczema and days lost through 
illness, with consequent social and economic effects (10, 11, 12, 13, 14, 15). There is 
also a three times higher prevalence than for non-sufferers of employment instability, 
sickness absence, disability, need for rehabilitation and early retirement in adults with 
hand eczema. Career disruption, lower income and financial losses due to the extra 
expenses incurred by having hand eczema have also been reported. The condition 
clearly has negative repercussions on quality of life and social interaction (14, 15, 16).  
The incidence of hand eczema in children, adolescents, women of reproductive age and 
the elderly is greater than in adult men. The one-year prevalence of hand eczema has 
been estimated to be as high as 10% of the total population (13, 17, 18, 19). Hand 
eczema often becomes chronic (persisting >5 years). A highly complex set of genetic, 
developmental, environmental (exposure to allergens and irritants), professional, and 
lifestyle factors contribute to its aetiology and prognosis. Domestic conditions such as 
wet-work exposure, the use of detergents and cleaning products, taking care of small 
children at home and the use of protective measures may also play a role (20). The 
repercussions in the lives of those affected are therefore complex and may add to the 
difficulty of protecting the hands.  
Assessing the burden of skin diseases in different segments of the population is crucial 
for evidence-based allocation of resources and to appropriately plan psychodermatology 
services in a global health perspective (21).  An appropriate methodology for achieving 
this assessment is still to be agreed. Patients with skin disease should receive advice on 
how to cope with accompanying psychological and social difficulties (7, 8, 12, 14, 16, 
22). An estimate of the prevalence of mental disorders among hand eczema patients 
(within the more general framework of other skin diseases) may contribute to a better 
understanding of the true impact of this disease.  
The aim of this study was to assess the correlation of several psychosocial variables 
with the burden posed by hand eczema on patients. Different population characteristics 
of patients with hand eczema were compared to healthy controls. In addition depression, 
anxiety, general quality of life (QoL) and dermatology specific QoL were measured in 
comparison to controls, and confounding factors, including gender, and their 
correlations were assessed.  
 
MATERIALS AND METHODS 
 
Study design 
This work is based on data from a European, multicenter, observational, cross-sectional 
study (9). Between November 2011 and February 2013, participants were recruited 
from dermatological outpatient clinics in 13 countries. At each clinic, consecutive 
patients were invited to participate on one or more random days until a study population 
of 250 was achieved. Inclusion criteria were: to be at least 18 years old; to be able to 
read and write the local language; and to not be suffering severe psychosis. Participants 
were asked to complete an initial questionnaire before undergoing a clinical 
examination. 
 
All patients participating in the study were examined by a dermatologist, who recorded 
the main dermatological diagnosis and the severity of the condition; some patients had 
more than one skin disease.  The presence of chronic comorbidities (cardiovascular 
disease; chronic respiratory disease; diabetes; rheumatic disease and/or any other 
chronic illnesses) was recorded. This information was asked by the dermatologist and 
then confirmed by checking the records. If there were doubts as to whether a skin 
disease was present (e.g. no diagnosis, no flare ups, and no itching) the patients were 
not included in the sample.  
 
In each centre, a control group of at least 125 subjects was recruited from among 
hospital employees working at the same institution but not the same department. The 
control groups recruited at each participating center included hospital staff, both direct 
health care workers such as nurses and doctors, and administrative staff. Participation 
was voluntary. Employees with a skin condition were excluded. The employees were 
informed about the study and, after giving written consent, were invited to answer the 
questionnaire. They were not examined; information on comorbidities was self-reported.  
The methodology of data collection is described in more detail in (9). 
 
Questionnaires 
The initial questionnaire dealt with the following socio-demographic variables: Age; 
Gender (male, female); Marital Status (single, married/cohabiting, separated/divorced, 
widowed; Socioeconomic Status (low, middle, high), and Education (Primary, 
Secondary, Higher Education, University). Stress was assessed by the question: ‘Have 
you experienced any stressful life events during the last 6 months?’ Suicidal ideation 
was contemplated by the question: ‘Have you ever thought of committing suicide?’ 
Subjects were also asked whether or not they were experiencing any itch. 
  
Symptoms of depression and anxiety (the main outcome variables) were assessed with 
the Hospital Anxiety and Depression Scale (HADS), a well-validated instrument with 
good psychometric properties regarding the presence and severity of anxiety disorders 
and depression (23, 24, 25). The HADS includes seven items concerning anxiety and 
seven concerning depression, each with four possible responses. For anxiety and 
depression, a score from 0 to 7 is considered as normal; from 8 to 10 is borderline; and 
11 to 21 is a case that requires further examination or treatment. The instrument was 
used in the validated translations for the languages of the countries involved.  
 
The Dermatology Life Quality Index (DLQI) (26) is the most frequently used 
instrument in randomised controlled dermatology studies. It is validated for adult 
dermatology patients aged 16 and over. It consists of 10 questions concerning patients’ 
perception of the impact of skin diseases on different aspects of their health related QoL 
over the last week, covering the domains: Symptoms and feelings, Daily activities, 
Leisure, Work and/or School, Personal relationships, and Treatment. Each response is 
scored on a 4-point Likert scale: Not at all/Not relevant (0); A little (1); A lot (2); Very 
much (3). Scores of individual items (0-3) are added to provide a total score of 0-30; 
higher scores mean a more impaired QoL (27). 
 
The EQ-5D health questionnaire is a simple generic measure of health status for clinical 
and economic appraisal (28). It is applicable to a wide range of health conditions and 
treatments, offers a simple descriptive profile and a single index value for health status. 
The 5 dimensions of the EQ-5D descriptive system are divided into 3 levels of 
perceived problems: Level 1 (no problems); level 2 (some problems); and level 3 
(extreme problems). An individual’s state of health is defined by combining one level 
from each of the 5 dimensions; there are therefore 35 =243 possible definitions of a 
person’s health status. The EQ VAS records participants’ self-rated health on a vertical 
visual analogue 100-degree scale (0 = “worst imaginable health state”; 100 = “best 
imaginable health state”). 
 
 
Statistical analysis 
In the multicenter dermatological study (9), statistical power was calculated on the basis 
of the prevalence of depression in the general population (estimated as 9%) and the 
higher prevalence expected in the population suffering dermatological conditions (29, 
30).  
 
Firstly, a descriptive analysis was conducted according to numbers and percentages for 
categorical variables. For quantitative variables mean and standard deviation (SD) were 
calculated if the variable could be explained as a normal distribution, or median and 
interquartile range (IR) were calculated if the variable did not follow a normal 
distribution.  
 
Secondly, to evaluate the relationship between the most important psychological 
variables (depression, anxiety, stress and suicidal ideation) in cases and controls, we 
used the χ2-test and Fisher’s exact test for categorical variables.  Where Pearson criteria 
were not met, we used the Fisher exact test.  In the comparison between the patients and 
controls by gender, the Mann–Whitney U test was introduced because the variables did 
not follow a normal distribution. Analysis of the main questionnaire and the HADS, 
EQ5D and DLQI questionnaires included stratification by gender. 
 
In order to assess the relationship of different independent variables with depression and 
stress, multivariate logistic regression models adjusted by age were implemented. The 
ORs were calculated from the estimated regression coefficients B of the logistic 
regressions; the exponential of the coefficient gives the OR. 
 
The statistical analysis was conducted with SPSS software (IBM SPSS Statistics for 
Windows, Version 19.0) and the p-value threshold was considered to be 0.05 in order to 
accept or reject the null hypothesis. 
 
 
RESULTS 
 
Of the 3,635 dermatology patients who completed the original study  (9), 143 (3.9%) 
were hand eczema patients. There were 86 (60%) women (mean age 45.5 years, SD = 
14.7, range 21-74) and 57 men (mean age 49.0 years, SD = 14.7, range 19-76) with 
hand eczema. The control population consisted of 900 women (mean age 40.0 years, SD 
= 13.3, range 18-85) and 453 men (mean age 40.0 years, SD = 14.2, range 18-89).  
    
The 143 patients with hand eczema were recruited from 13 countries. Turkey and 
Norway had the biggest sample with 24 and 20 cases each. On the other hand, Spain, 
Belgium, France and Hungary had the smallest sample with 0, 2, 5, and 5 cases each. 
These individual country numbers were too small to allow any meaningful comparisons 
by country. 
 
Table 1 gives details of age, marital status, socioeconomic status, hand eczema severity, 
stress, suicidal ideation, itching, depression and anxiety.  
 
The severity of the disease was determined by the dermatologist. As the subtype of hand 
eczema was not recorded in this study, it was not possible to analyse the data based on 
subtypes.  In Table 1, data concerning the subjects who were widowed or divorced were 
excluded in order to create a 2x2 contingency table with dichotomous data, to apply the 
Fisher test. The frequencies in the different groups are very similar, demonstrating lack 
of difference between the groups. 
 
The mean age for all 143 patients was 45.2 years (SD 15.2). 60.6% were married and 
72.9% were described as at a medium socioeconomic level. The mean duration of 
disease was 7.7 years (SD=11.9), and the dermatological diagnosis was known by 
56.8% of patients. Severity was mild for 51.6%, moderate for 37.5%, and severe for 
10.9%. Hand eczema patients rated 15.9% in depression and/or anxiety, itching was 
present in 81.2% of the cases and suicidal ideation in 14.2%.  
 
 
Include Table 1 
  
 
The results of the HADS, EQ5D and DLQI, compared with controls, are given by 
gender in Table 2. There were statistically significant differences between women 
patients and women controls for anxiety and depression (measured by HADS) and in all 
subscales measured by the EQ5D. Men patients versus men controls showed 
statistically significant differences in most EQ5D subscales except for anxiety and 
depression. In men, the differences were insignificant for anxiety and depression in both 
the HADS and in the EQ5D anxiety/depression subscales. 
 
The median total DLQI score for all patients with hand eczema was 7. A DLQI score of 
7 means that a skin disease is having a moderate effect on the patient’s life (27). 
However this is a median score for a population and so individual patients in the cohort 
had a range of scores. There was no significant difference in the total DLQI scores or in 
the DLQI sub-domains between men and women (Table 2).  There were strong 
correlations (p<0.01) between the total DLQI scores and the severity of the skin disease, 
and also with cardiac comorbidity (Table S1). The most prevalent comorbidity was 
cardiovascular (15.3%): the prevalence of each of the other comorbidities was <6%. 
Include Table 2 
 
The regression analysis adjusted for age in Table 3 shows that patients with higher 
suicidal ideation, p = 0.038 and adjusted OR= 3.2 (1.06-9.79); higher widowed/divorced 
status, p < 0.001 and OR= 2.69 (1.56-4.64); and lower socioeconomic status, p < 0.001 
and OR= 6.9 (2.45-19.24) had a greater chance than persons without suicidal ideation, 
lower widowed/divorced status and higher socioeconomic status to fulfil the HADS 
criterion (adjusted for the age). In summary, patients with high suicidal ideation, low 
socioeconomic status and widowed or divorced were more likely to experience anxiety 
and depression (OR>1, p<0,05); whereas, widowed or divorced or low socioeconomic 
patients were more likely to experience stress (OR>1, p<0,01). In summary, patients 
with high suicidal ideation, low socioeconomic status and who were widowed or 
divorced were more likely to fulfil the HADS criteria for anxiety [(Odds ratio (OR)>1, 
p=0.038, p<0.001 and p<0.001 respectively]; low socioeconomic status (p=0.007) and 
widowed or divorced patients (p=0.001) were more likely to fulfil the HADS criteria for 
depression. For patients with severe and moderate hand eczema, only the widowed-
divorced variable was statistically significant (p = 0.041 and OR= 0.29 (0.08-0.95)).  
 
 
Include Table 3 
 
 
DISCUSSION 
 
Considerable differences were found between hand eczema patients and the control 
group. Patients report significantly higher levels of stress, suicidal ideation, depression, 
and anxiety. In addition, significant gender differences were also found, e.g. suicidal 
ideation was considerably higher for the patients than the controls (p = 0.019), though 
this difference was only statistically significant for women (p = 0.007). Women also 
reported significantly higher levels of anxiety (p = 0.006) and depression (p < 0.001) 
than men. With the EQ-5D subscales, there were also significant gender differences, 
with the exception of the anxiety/depression subscale for men. When we analysed 
gender differences between patients (not shown in Table 2), the only significant result 
was for the EQ5D anxiety/depression subscale (p < 0.001). These findings and the 
associated gender bias are in agreement with the results of previous studies (11, 32, 33, 
34). Although this gender difference has been found in previous studies, we feel that it 
has not been sufficiently discussed in the literature. It can be argued that the design of 
the QoL questionnaires only partially allows the revealing of gender differences in 
behavioural and exposure patterns and the higher degree of emotional distress and 
discomfort reported by women (35, 36). QoL questionnaires are usually specifically 
designed to be of equal relevance to men and women and so their design may be 
counterproductive to assessing these more subtle differences. 
 
Table 2 gives the results of the DLQI (only completed by patients). There were 
consistent gender differences in all subscales but none were statistically significant. 
This might be due to the relatively small number of patients in the sample. Moreover, 
there is doubt as to whether the DLQI subscales adequately consider a number of 
factors that may contribute to consistent gender differences, such as the fact that women 
tend to make more frequent use of perfumes, moisturisers and cosmetics (for aesthetic 
or occupational reasons) and often have more contact with cleansing products, rubber 
gloves, liquids and other allergens linked to domestic tasks and child care (22, 35). The 
uneven gender distribution of hand eczema and its psychosocial consequences 
represents a public health challenge in terms of aetiology, prevention, and treatment 
(37). 
 
The Spearman correlations for the HADS, EQ5D and DLQI and the sociodemographic 
variables and other conditions (stress, suicidal ideation, severity and cardiac 
comorbidity) show that rates of high anxiety (measured by the HADS) correlate 
positively with marital status and suicidal ideations, and negatively with socioeconomic 
status. The correlations between diagnostic severity and the DLQI subscales (symptoms, 
daily activities, leisure and treatment) are also noteworthy. It has been argued (34) that 
higher levels of mental distress may lead to treatment discontinuation or non-
compliance and can also influence recovery and duration. All the results in this section 
are in line with findings from other studies (11, 22, 31, 32, 34, 38, 39). Taken together, 
these studies give a broad assessment of the psychosocial burden generated by hand 
eczema. 
 
The hands play an essential role in the human socialisation processes - at work, in 
leisure activities, in the self-image of the individual or in the gestures that accompany 
communication processes. Most human actions depend on the hands and their 
appearance has a fundamental influence on a person’s social life, far beyond a merely 
cosmetic value. Hand eczema, as a chronic inflammatory dermatosis with a relapsing 
course and poor prognosis (31, 34), is often provoked, maintained or aggravated as a 
consequence of non-apparent factors which are related to ongoing psychosocial 
processes (7, 8, 12, 22, 40). Progressively exploring, understanding, and explaining the 
global nature of the psychosocial burden is necessary for improved, holistic treatment.    
 
There are several limitations to this study. The main limitation is the small size of the 
sample population of hand eczema patients. Also, the use of questionnaires does not 
allow the face-to-face interaction of a clinical interview, where it is easier to detect 
possible mental health disorders. This is one of the drawbacks of quantitative research, 
which could be overcome with the use of qualitative research. However, we consider 
the use of questionnaires useful for gathering information. We could consider a post-hoc 
analysis in order to clarify the role of the age in this kind of patients, seeing that 
confounder variables such as socioeconomic status or marital status can be related to 
age. 
 
Other limitations include the recruitment procedures for patients and controls and the 
clinicians’ impression of relatively mild objective sign-based severity of hand eczema in 
the sample population.  In contrast, the DLQI median score of 7, interpreted as 
moderate impact on quality of life, is an example of quality of life impact not 
necessarily being directly related to the objective severity of skin disease. 
 
This study has explored the substantial psychological burden caused by hand eczema, 
the gender differences involved in its impact and the difficulties that the condition can 
cause at work and at home. Depression, anxiety, stress, suicidal ideation and diagnostic 
severity were significantly correlated, between themselves, and with other confounders. 
The gender issue represents a serious problem that merits further, more extensive 
research.   
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Table 1 – Results from the questionnaires of main population.  Characteristics 
of hand eczema patients (143) and global controls (1,359). 
  
 Patients 
results, 
n=143. N (%) 
Patients 
Women, 
n=86. N (%) 
Controls 
Women, 
n=900. N (%) 
P-value 
patients 
vs. 
controls 
(women) 
Patients 
Men, n=57. 
N (%) 
Controls 
Men, 
n=453. N 
(%) 
P-value  
Patients 
vs. 
controls 
(men) 
P-value 
Patients 
Men vs. 
Women. 
Complete 
sample 
Age (years) 45.2 
(DE=15.2) 
45.50 (IR=22) 40 (IR=21) NS* 49 (IR=24) 40 (IR=21) 0.004* NS* 
Marital status 
Single 
Married 
Divorced 
Widowed 
 
33 (25.0%) 
80 (60.6%) 
13 (9.8%) 
6 (4.5%) 
 
21 (25.3%) 
49 (59.0%) 
8 (9.6%) 
5 (6.0%) 
 
221 (24.6%) 
558 (62.0%) 
91 (10.1%) 
30 (3.3%) 
NS*** 
 
 
12 (24.5%) 
31 (63.3%) 
5 (10.2%) 
1 (2.0%) 
 
 
141 (31.1%) 
281 (62.0%) 
27 (6.0%) 
4 (0. 9%) 
NS*** NS*** 
1Socioeconomic 
Low 
Middle 
High 
 
26 (18.5%) 
102 (72.9%) 
12 (8.5%) 
 
18 (21.4%) 
56 (66.7%) 
10 (11.9%) 
 
146 (16.3%) 
680 (75.9%) 
70 (7.8%) 
NS** 
 
 
8 (14.3%) 
46 (82.1%) 
2 (3.6%) 
 
69 (15.3%) 
330 (73.3%) 
51 (11.3%) 
NS*** NS*** 
2Severity of 
hand eczema 
Mild 
Moderate 
Severe 
 
 
48 (51.6%) 
48 (37.5%) 
14 (10.9%) 
 
 
35 (46.1) 
33 (43.4) 
8 (10.5) 
 
 
─ 
─ 
─ 
 
 
─ 
─ 
─ 
 
 
31 (59.6) 
15 (28.8) 
6 (11.5) 
 
 
─ 
─ 
─ 
 
 
─ 
─ 
─ 
 NS** 
3Stress 58 (41.4%) 34 (40.5%) 275 (30.7%) 0.044** 24 (42.9%) 137 (30.5%) 0.045** NS** 
4Suicide 20 (14.2%) 14 (16.5%) 50 (7.3%) 0.007** 6 (10.7%) 38 (10.0%) NS** NS** 
5Itch 112 (81.2%) 69 (82.1%) 55 (7.8%) <0.001** 43 (79.6%) 33 (8.5%) <0.001** NS** 
6Depression 21 (15.9%) 16 (20.3%) ─ ─ 5 (9.4%) ─ - NS** 
7Anxiety 21 (15.9%) 18 (22.8%) ─ ─ 3 (5.7%) ─ - 0.009** 
 
 
 
*   Mann-Whitney U test 
** 2-test 
*** Fisher exact test, excluding Divorced and Widowed 
 
Abbreviations: IR - interquartile range; N - population number; NS - non-significant.  
 
Self-reported variables (except hand eczema severity) from questionnaire: 
 
1 “Which is your socioeconomic level?” Low/Middle/High 
2 Hand eczema severity was assessed and graded by the dermatologist. 
3 “Have you had any stressful life events during the last six months?” Yes/No 
4 “Have you ever thought of committing suicide?” Yes/No 
5 “ Do you itch now?” Yes/No 
6Answers recorded by dermatologists responding to question “Do you see depressive signs in the patient? 
Yes/No” 
7Answers recorded by dermatologists responding to question “Do you see anxiety signs in the patient? 
Yes/No” 
Table 2 - Results of the HADS, EQ5D and DLQI questionnaires (gender differences 
between patients and the control group, separate and aggregated)  
 
 Women 
Patients, 
n=86.  
Median (IR) 
Women  
Controls, 
n=900. 
Median 
(IR) 
P-value* 
Patients 
vs 
controls 
(female) 
Men  
Patients, 
n=57. 
Median (IR) 
Men 
Controls, 
n=453. 
Median (IR) 
P-value*  
Patients 
vs 
controls 
(male) 
P-value* 
Patients 
vs 
Controls. 
Complete 
sample 
**HADS 
Anxiety 
Depression 
 
7.00 (6.00) 
4.00 (8.00) 
 
5.00 (5.00) 
3.00 (5.00) 
 
0.017 
<0.001 
 
5.00 (7.50) 
3.00 (8.00) 
 
5.00 (4.00) 
3.00 (5.00) 
 
NS 
NS 
 
0.026 
<0.001 
EQ5D 
Mobility 
Self-Care 
Usual Activities 
Pain/Discomfort 
Anxiety/Depression 
Health Status (own 
health) 
 
1.00 (1.00) 
1.00 (0.00) 
1.00 (1.00) 
2.00 (1.00) 
2.00 (1.00) 
70.00 (34.00) 
 
1.00 (0.00) 
1.00 (0.00) 
1.00 (0.00) 
1.00 (1.00) 
1.00 (1.00) 
85.00 (20.0) 
 
 
<0.001 
<0.001 
<0.001 
<0.001 
<0.001 
<0.001 
 
 
1.00 (1.00) 
1.00 (0.00) 
1.00 (1.00) 
2.00 (1.00) 
1.00 (1.00) 
72.50 (29.00) 
 
1.00 (0.00) 
1.00 (0.00) 
1.00 (0.00) 
1.00 (1.00) 
1.00 (1.00) 
85.00 (15.00) 
 
<0.001 
<0.001 
<0.001 
<0.001 
NS 
<0.001 
 
 
<0.001 
<0.001 
<0.001 
<0.001 
<0.001 
<0.001 
 
DLQI Total 
Symptoms and feelings 
Daily Activities 
Leisure 
Work and School 
Personal relationships 
Treatment 
7.00 (9) 
3.00 (2.75) 
1.00 (3.00) 
1.00 (6.00) 
1.00 (2.00) 
0.00 (1.50) 
0.00 (1.00) 
─ 
─ 
─ 
─ 
─ 
─ 
─ 
─ 
─ 
─ 
─ 
─ 
6.50 (8.75) 
2.00 (3.00) 
1.00 (2.75) 
1.00 (6.00) 
1.00 (2.00) 
0.00 (2.00) 
0.00 (1.00) 
─ 
─ 
─ 
─ 
─ 
─ 
 NS 
NS  
NS 
NS 
NS 
NS 
NS 
 
 
* Mann-Whitney U test 
 
**HADS score for both the dimension of Anxiety and Depression are as follows: 0 to 7 is considered a 
normal case, from 8 to 10 a borderline case, and from 11 to 21 a case in need of further examination or 
treatment. 
 
Abbreviations: IR - interquartile range; NS - non-significant.  
Table 3 - Depression (HADS≥11) and stress in hand eczema patients (n=143): 
relationships with confounders and risk values (OR). 
 
 Depression HADS≥11 STRESS 
 P-
value

 
OR*, (CI 95%) 
P-value
 OR*, (CI 95%) 
Suicidal ideation/no 
suicidal ideation 
0.038 3.23 (1.06-9.79) 0.074 2.41 (0.92-6.35) 
Cardio 
comorbidity/no 
cardio comorbidity 
0.113 2.564 (0.79-8.22) 0.806 1.13 (0.42-3.08) 
Widowed-
Divorced/rest of the 
status (single or 
married) 
<0.001 2.69 (1.56-4.64) 0.01 3.90 (1.38-11.05) 
Low socioeconomic 
status/rest of the 
status (middle or 
high) 
<0.001 6.87 (2.45-19.24) 0.007 3.45 (1.41-8.44) 
Women/men 0.482 1.42 (0.53-3.78) 0.779 0.91 (0.46-1.80) 
Foreign/native 0.564 1.62 (0.31-8.42) 0.357 0.46 (0.09-2.38) 
*Adjusted OR adjusted by age  
 
: p-value of null hypothesis OR=1 
Abbreviations: CI: Confidence interval; OR: Odds ratio 
 
 
